Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 625

1.
2.

Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.

Funeshima N, Fujino M, Kitazawa Y, Hara Y, Hara Y, Hayakawa K, Okuyama T, Kimura H, Li XK.

J Gene Med. 2005 May;7(5):565-75.

PMID:
15543532
3.
4.

Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.

Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA.

J Immunol. 2000 Apr 1;164(7):3596-9.

5.

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB.

J Exp Med. 2002 Aug 19;196(4):459-68.

6.

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, Dilloo D.

Blood. 2004 Jun 15;103(12):4619-21. Epub 2004 Mar 4.

7.

Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.

Le Rond S, Gonzalez A, Gonzalez AS, Carosella ED, Rouas-Freiss N.

Immunology. 2005 Nov;116(3):297-307.

8.

Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).

Sarkhosh K, Tredget EE, Karami A, Uludag H, Iwashina T, Kilani RT, Ghahary A.

J Cell Biochem. 2003 Sep 1;90(1):206-17.

PMID:
12938169
9.

Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.

López AS, Alegre E, LeMaoult J, Carosella E, González A.

Mol Immunol. 2006 Jul;43(14):2151-60. Epub 2006 Feb 21.

PMID:
16490253
10.

Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines.

Weber WP, Feder-Mengus C, Chiarugi A, Rosenthal R, Reschner A, Schumacher R, Zajac P, Misteli H, Frey DM, Oertli D, Heberer M, Spagnoli GC.

Eur J Immunol. 2006 Feb;36(2):296-304.

11.

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, Mellor AL.

Immunity. 2005 May;22(5):633-42.

12.

Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.

Qian F, Villella J, Wallace PK, Mhawech-Fauceglia P, Tario JD Jr, Andrews C, Matsuzaki J, Valmori D, Ayyoub M, Frederick PJ, Beck A, Liao J, Cheney R, Moysich K, Lele S, Shrikant P, Old LJ, Odunsi K.

Cancer Res. 2009 Jul 1;69(13):5498-504. doi: 10.1158/0008-5472.CAN-08-2106. Epub 2009 Jun 2.

13.

The immunoregulatory function of indoleamine 2, 3 dioxygenase and its application in allotransplantation.

Jalili RB, Forouzandeh F, Bahar MA, Ghahary A.

Iran J Allergy Asthma Immunol. 2007 Dec;6(4):167-79. Review.

14.

Suppression of T-cell response and prolongation of allograft survival in a rat model by tryptophan catabolites.

Dai X, Zhu BT.

Eur J Pharmacol. 2009 Mar 15;606(1-3):225-32. doi: 10.1016/j.ejphar.2008.12.053. Epub 2009 Jan 17.

PMID:
19374879
15.

Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?

Löb S, Ebner S, Wagner S, Weinreich J, Schäfer R, Königsrainer A.

Transplantation. 2007 Feb 27;83(4):468-73.

PMID:
17318080
16.

Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation.

Brandacher G, Margreiter R, Fuchs D.

Curr Drug Metab. 2007 Apr;8(3):273-82. Review.

PMID:
17430115
17.

High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death.

Habibi D, Jalili RB, Forouzandeh F, Ong CJ, Ghahary A.

J Cell Physiol. 2010 Oct;225(1):196-205. doi: 10.1002/jcp.22220.

PMID:
20648630
18.

Tumor immune escape mediated by indoleamine 2,3-dioxygenase.

Zamanakou M, Germenis AE, Karanikas V.

Immunol Lett. 2007 Aug 15;111(2):69-75. Epub 2007 Jul 2. Review.

PMID:
17644189
19.

Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?

Terness P, Chuang JJ, Bauer T, Jiga L, Opelz G.

Blood. 2005 Mar 15;105(6):2480-6. Epub 2004 Nov 30.

20.

Indoleamine 2,3-dioxygenase is necessary for cytolytic activity of natural killer cells.

Kai S, Goto S, Tahara K, Sasaki A, Tone S, Kitano S.

Scand J Immunol. 2004 Feb;59(2):177-82.

Supplemental Content

Support Center